entertainment -WSS

entertainment

author：focus 2025-09-02 08:19:56 - browse：395

Adobe

CVS Health viewed Amy Bricker as a potential CEO. But she won’t be going to the health care conglomerate anytime soon.

A federal appeals court has ruled Bricker, a former high-ranking executive at Cigna, cannot jump to CVS because it would violate her noncompete agreement that she signed while at Cigna. The appeals court’s decision backs up what a district court had previously ruled.

The case is a prominent example of why the health care industry, and corporate America writ large, does not want noncompetes to go away. In April, the Federal Trade Commission approved a nationwide ban on most such agreements, which prevent workers from moving to other jobs, but companies and corporate lobbying groups have already sued to squash the ban.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Anthos stroke drug appears safer than common blood thinner

leisure time

WSS

AI models in health care face new federal disclosure requirements

FDA approves world's first CRISPR

Pfizer plans to depart BIO

Childhood cancer progress stalls for Black, Hispanic kids: Report

Why medical students are struggling with mental health

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

hotspot

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

knowledge

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Hospitals look to new technology to keep health care workers safe

Alkermes shareholders re

PBM reforms clear House panel

Continuity nursing helped my family in our darkest PICU moments

Wegovy, Zepbound and weight loss drugs that preserve muscle

Peter Hotez and the public health issue of online harassment

NYU radiologists take on the challenge of expensive MRI machines

Medical leaders decry Supreme Court decision on affirmative action

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Wikipedia

Patients' immediate access to test results puts radiologists in a bind

Surge of respiratory disease in China has likely explanation

What causes an itch? Researchers may have solved the mystery

CMS should re

FDA approves world's first CRISPR

In diabetes hearing, Sanders takes on a new foe: food makers

hotspot

leisure time

focus

hotspot